ANATARA LIFESCIENCES LTD — Investor Relations & Filings

Anatara Lifesciences Ltd is a life sciences company focused on the development of evidence-based solutions for gastrointestinal health in both humans and animals. The company specializes in creating non-antibiotic oral products that address gut health issues and inflammatory diseases. Its lead human health product, Gastrointestinal Re-Programming (GaRP), is a multi-component dietary supplement designed to manage symptoms of Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD) by restoring the gut lining and balancing the microbiome. In the animal health sector, the company developed Detach, a natural, non-antibiotic treatment for diarrheal disease in livestock. Anatara’s research focuses on bridging the gap between conventional medicine and natural therapies through rigorous clinical validation, targeting markets seeking sustainable alternatives to traditional antibiotics and effective management of chronic digestive conditions.